STADA and Alvotech launch the first approved biosimilar of Stelara on the European market
Read more
Roche reports the Prasinezumab aids in early-stage Parkinson's
The main goal of the Phase IIb study wasn't met with statistically significant results, but there is still some good news On Dec. 18, 2024, Roche shared results from a Phase IIb study (PADOVA) where prasinezumab, an investigational monoclonal antibody (mAb), did not meet the study’s primary
Novo Nordisk is Funding New Manufacturing Facility in Denmark
Novo Nordisk will establish a modular, adaptable production facility in Odense, Denmark Novo Nordisk announced a $1.2 billion production plant in Odense, Denmark, on Dec. 16, 2024. The facility will house present and future hemophilia treatment products. In a press release, Novo Nordisk said this investment is its first
Lilly and Amgen - Major Expansions of US Manufacturing Sites
Lilly will invest $3 billion in its newly purchased Wisconsin manufacturing site, and Amgen will invest $1 billion in North Carolina. Companies Amgen of Holly Springs, North Carolina, and Eli Lilly and Company (Lilly) of Kenosha County, Wisconsin, have each declared intentions to increase production capacity. Amgen has announced a
New Pharmaceutical Shortages Surveillance Platform in Europe
The new system for reporting medication shortages by holders of market authorizations is now active With the launch of its primary functions, the European Shortages Monitoring Platform (ESMP) was announced by the European Medicines Agency (EMA) on November 28, 2024. With the help of ESMP, MAHs can regularly report shortages